Philippos Costa

Philippos Costa is an Assistant Professor of Medicine at Yale School of Medicine, specializing in Medical Oncology and Hematology. He completed his MD at Universidade Federal do Vale do São Francisco (2016), followed by residencies at Universidade Federal de Uberlândia (2018) and University of Miami (2022), and a fellowship at Yale (2025). His research focuses on sarcomas, particularly desmoid tumors, angiosarcomas, and GIST, with an emphasis on systemic therapies, immunotherapy strategies, and patient advocacy in developing countries.

• MD (2016) - Universidade Federal do Vale do São Francisco
• Residency (2018) - Universidade Federal de Uberlândia
• Residency (2022) - University of Miami
• Fellowship (2025) - Yale University

Dr. Costa's work explores the genetic landscape of angiosarcomas, dose escalation in GIST therapies, and imaging biomarkers for desmoid tumor response. He leads the Sarcoma Program and Early Phase Clinical Trial Program at Yale. His collaborations include frequent co-authors like Hari Deshpande and Kiran Turaga.

He received The Vanessa Blumer Research Scholar Award (2022) for his contributions. His recent publications address chemotherapy optimization, real-world treatment efficacy, and interdisciplinary approaches to rare cancers.